Measuring current and future cost of skin cancer in England

Journal of Public Health (United Kingdom)

Volumn 36, Issue 1, 2014, Pages 140-148

  Vallejo Torres, L ^a   Morris, S ^a   Kinge, J M ^b   Poirier, V ^c   Verne, J ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b STATISTICS NORWAY   (Norway)

^c South West Public Health Observatory ^*  (United Kingdom)

Author keywords

burden of disease; cost; cost of illness; skin cancer

Indexed keywords

EID: 84897692289     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdt032     Document Type: Article

References (34)

1. Office for National Statistics. Cancer Statistics: Registrations. Series MB1 no. 37. Office for National Statistics, London. 2009a http://www.ons.gov.uk/ ons/rel/vsob1/cancer-statistics-registrations-england-series-mb1-/no-37-2006/ index.html (July 2010, date last accessed).
2. Office for National Statistics. Mortality Statistics: Deaths Registered in 2008: DR-08. Office for National Statistics, London. 2009b http://www.ons.gov.uk/ons/rel/vsob1/mortality-statistics-deaths-registeredin- england-and-wales-series-dr-/2008/index.html (July 2010, date last accessed).
3. Cancer Research UK. Skin Cancer Statistics-Key Facts. 2012 http://info.cancerresearchuk.org/cancerstats/keyfacts/skin-cancer/ (June 2012, date last accessed).
4. National Cancer Intelligence Network. Data Briefing: The Importance of Skin Cancer Registration. 2010. http://www.ncin.org. uk/publications/data- briefings/skin-cancer-registration.aspx (June 2011, date last accessed).
5. Hall PS, Rautenberg TA, McCabe C. Cost analysis for cancer subgroups. Br J Cancer 2009;100:1513.
6. Chapko MK, Liu CF, Perkins M et al. Equivalence of two healthcare costing methods: bottom-up and top-down. Health Econ 2009;18:1188-201.
7. Morris S, Cox B, Bosanquet N. Cost of skin cancer in England. Eur J Health Econ 2009;10:267-73.
8. National Cancer Intelligence Network. Cost of skin cancer in England, including projections to 2020. UKARC & NCIN Conference. 2011. http://www.ncin.org.uk/news-and-events/conferences/2011.aspx (June 2012, date last accessed).
9. Curtis L. Unit Costs of Health and Social Care. PSSRU, University of Kent, Canterbury, 2008.
10. Department of Health. Hospital Episodes Statistics, England: Financial Year 2007-08: Primary diagnosis 3 Character. Department of Health. 2009. http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID= 1937&categoryID=245 (July 2010, date last accessed).
11. Office of Population Censuses and Surveys. 1995. Morbidity statistics from general practice: fourth national study 1991-1992, series MB5 no. 3. HMSO.
12. Department of Health. 2007. NHS Reference Costs 2005-06. Department of Health. http://webarchive.nationalarchives.gov. uk/+/www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-062884 (July 2010, date last accessed).
13. Marsden J, Newton-Bishop J, Burrows L et al. British Association of Dermatologists Clinical Standards Unit. Revised UK guidelines for the management of cutaneous melanoma. Br J Dermatol 2010;163:238-56.
14. Telfer N, Colver G, Morton C. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008;159:35-48.
15. Motley R, Preston P, Lawrence C. 2009 Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. British Association of Dermatologists. Revision date 12 August 2009.
16. Goulding J, Levine S, Blizard RA et al. Dermatology surgery: a comparison of activity and outcomes in primary and secondary care. Br J Dermatol 2009;161:110-4.
17. Jackson A, Morgan D, Ellison R. Diagnosis of malignant melanoma by general practitioners and specialists. Postgrad Med J 2000;76:295-8.
18. Hussain S, Shams N, Garioch S. Managing squamous cell carcinomas: auditing the mode of referral to secondary care and adequacy of surgical excision. Br J Dermatol 2008;159:104.
19. Malhomme de la Roche H, Lucke T. Audit of excision rates of basal cell carcinomas in primary and secondary care in a county over 1 year. Br J Dermatol 2008;159:111-2.
20. Batchelor R, Stables G. An audit of the management of cutaneous squamous cell carcinoma according to the multiprofessional guidelines. Br J Dermatol 2006;154:1202-3.
21. Gudi V, Ormerod A, Dawn G et al. Scottish Dermatological Society. Management of basal cell carcinoma by surveyed dermatologists in Scotland. Clin Experiment Dermatol 2006;31:648-82.
22. Murchie P, Delaney E, Thompson Wet al. Excising basal cell carcinomas: comparing the performance of general practitioners, hospital skin specialists and other hospital specialists. Clin Experiment Dermatol 2008;33:565-71.
23. Orr D, Hughes L, Horgan K. Management of malignant melanoma of the head and neck. Br J Surg 1993;80:998-1000.
24. Keogh-Brown M, Fordham R, Thomas K et al. To freeze or not to freeze: a cost-effectiveness analysis of wart treatment. Br J Dermatol 2007;156:687-92.
25. Thomas J, Patocskai E. The argument against sentinel node biopsy for malignant melanoma. Br Med J 2000;321(7252):3-4.
26. National Institute for Health and Clinical Excellence. 2010 Costing Statement: Skin Cancer (update). http://guidance.nice.org.uk/CSGSTIM (August 2010, date last accessed).
27. Department of Health. 2010a. NHS Reference Costs 2008-09. Department of Health. http://www.dh.gov.uk/en/Publicationsand statistics/Publications/ PublicationsPolicyAndGuidance/DH-111591 (July 2010, date last accessed).
28. Department of Health 2010b Programme Budgeting Data. http://www.dh.gov. uk/en/Managingyourorganisation/Financeandplanning/Programmebudgeting/index.htm (July 2010, date last accessed).
29. Diffey BL. The future incidence of cutaneous melanoma in the UK. Br J Dermatol 2004;51:868-72.
30. Tinghög G, Carlsson P, Synnerstad I et al. Societal cost of skin cancer in Sweden 2005. Acta Dermato-Venereologica 2008;88(5):467-473.
31. O'Dea D. 2009 The cost of skin cancer to New Zealand. A Report to the cancer Society of New Zealand. October 2009.
32. Australian Institute of Health and Welfare. Health system expenditures on cancer and other neoplasms in Australia, 2000-01. Health and Welfare Expenditure Series Number 22. Canberra: AIHW, 2005.
33. Fransen M, Karahalios E, Sharma N et al. Non melanoma skin cancer in Australia. Med J Austr 2012;197(10):565-568.
34. Guy GP, Ekwueme DU. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Pharmacoeconomics 2011;29(10):863-74.